4148 — All Cosmos Bio-Tech Holding Balance Sheet
0.000.00%
Last trade - 00:00
- TWD2.97bn
- TWD2.60bn
- TWD2.83bn
- 82
- 50
- 39
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,088 | 851 | 775 | 1,346 | 1,571 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 363 | 574 | 458 | 728 | 505 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,789 | 1,827 | 2,302 | 3,367 | 2,818 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 648 | 606 | 629 | 679 | 803 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,640 | 2,614 | 2,970 | 4,111 | 3,674 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 175 | 221 | 562 | 682 | 790 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 594 | 628 | 980 | 1,744 | 1,419 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2,046 | 1,987 | 1,990 | 2,367 | 2,254 |
Total Liabilities & Shareholders' Equity | 2,640 | 2,614 | 2,970 | 4,111 | 3,674 |
Total Common Shares Outstanding |